{"schema_version":"secwatch.filing_event.v1","accession":"0001077183-25-000005","form_type":"8-K","ticker":"NEO","cik":"0001077183","company_name":"NEOGENOMICS INC","filed_at":"2025-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.878403+00:00","generated_at":"2026-05-28T04:26:45.918222+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"NeoGenomics CEO Chris Smith to retire April 1; board member Tony Zook named successor","bullets":["Chris Smith retires as CEO effective April 1, 2025; will serve as special advisor through Feb 2027 at $23,913/month.","Tony Zook, independent board member since June 2023, appointed CEO effective April 1; base salary $850k with 100% target bonus and ~$8M annual equity target.","Smith's retirement package includes pro-rated 2025 bonus, accelerated vesting of 265,452 restricted shares, and 12-month option exercise extension.","Company reaffirms FY2024 guidance: revenue $655–$667M, net loss $(81)–$(78)M, adjusted EBITDA $37–$40M.","NeoGenomics reported eight consecutive quarters of double-digit revenue growth under Smith's tenure."],"urls":{"canonical":"https://secwatch.observer/filing/0001077183-25-000005","json":"https://secwatch.observer/filing/0001077183-25-000005.json","markdown":"https://secwatch.observer/filing/0001077183-25-000005.md","text":"https://secwatch.observer/filing/0001077183-25-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000005/0001077183-25-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000005/neo-20250103.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T04:26:45.918222+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"49c209d877","claim":"Christopher Smith was appointed as special advisor at NEOGENOMICS INC.","evidence_excerpt":"The Special Advisor Agreement provides that Mr. Smith will serve as a special advisor to the Company’s Chief Executive Officer until February 26, 2027 in exchange for a fee of $23,913 per month.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000005/0001077183-25-000005-index.htm","confidence":0.85,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"special advisor"}],"fact_type":"executive_change"},{"claim_id":"766ec424ab","claim":"Christopher Smith departed as Chief Executive Officer at NEOGENOMICS INC.","evidence_excerpt":"Christopher Smith, the Company’s Chief Executive Officer and a member of the Company’s board of directors (the “Board”), will retire effective April 1, 2025","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000005/0001077183-25-000005-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retire"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"7af8ea6dba","claim":"Christopher Smith departed as member of the board of directors at NEOGENOMICS INC.","evidence_excerpt":"Christopher Smith, the Company’s Chief Executive Officer and a member of the Company’s board of directors (the “Board”), will retire effective April 1, 2025","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000005/0001077183-25-000005-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"retire"},{"label":"Role","value":"member of the board of directors"}],"fact_type":"executive_change"},{"claim_id":"ca5e09f480","claim":"Tony Zook was appointed as Chief Executive Officer at NEOGENOMICS INC.","evidence_excerpt":"On January 10, 2025, the Company announced the appointment of Tony Zook to replace Mr. Smith as Chief Executive Officer effective April 1, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000005/0001077183-25-000005-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}